As of Feb 10
| +0.27 / +0.54%|
The 22 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 65.00, with a high estimate of 71.00 and a low estimate of 54.00. The median estimate represents a +28.15% increase from the last price of 50.72.
The current consensus among 27 polled investment analysts is to Buy stock in St. Jude Medical. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.